Colchicine in Chronic Limb-Threatening Ischemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT07536373

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07536373
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07536373. Randomized; quadruple masking; primary purpose treatment. Start 2026-06-02 (actual); primary completion 2029-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine in Chronic Limb-Threatening Ischemia
Acronym
CIRCLE-Asia
Condition
Chronic Limb-Threatening Ischemia
Intervention (Drug)
Colchicine 0.5 MG Oral Tablet Once Daily
Intervention (Drug)
Placebo
Lead sponsor
Shin Kong Wu Ho-Su Memorial Hospital (class: other)
Collaborator
National Taiwan University Hospital (class: other)
Collaborator
Chi Mei Medical Hospital (class: other)
Collaborator
Taipei Veterans General Hospital, Taiwan (class: other government)
Collaborator
Chang Gung Memorial Hospital (class: other)

Record details

Record id
cardio:ct-nct07536373
Content hash
fce7ed8ff55aa3850befba4fd083e07fec48cea35bc22622c89ae01e6dfe7ee4